Carvedilol Inhibits Pressure-Induced Increase in Oxidative Stress in Coronary Smooth Muscle Cells.

  • YASUNARI Kenichi
    Department of Cardiology, Graduate School of Medicine, Osaka City University
  • MAEDA Kensaku
    Department of Cardiology, Graduate School of Medicine, Osaka City University
  • NAKAMURA Munehiro
    Department of Cardiology, Graduate School of Medicine, Osaka City University
  • YOSHIKAWA Junichi
    Department of Cardiology, Graduate School of Medicine, Osaka City University

この論文をさがす

抄録

The cellular mechanisms by which hypertension enhances atherosclerosis are still not known in detail. Recently, evidence has been obtained that oxidative stress plays a role in the pathogenesis of pressure-induced atherosclerosis. We examined the effects of pressure on oxidative stress in cultured human coronary smooth muscle cells (SMCs). Application of increased pressure (+100 mmHg) with He gas for 48 h increased oxidative stress of measured by flow cytometry by 71% and F2-isopretane by 77%. Increased pressure also increased the activities of phospholipase D (PLD), and particulate protein kinase C (PKC). The PLD inhibitor suramin 100 μmol⁄l, 1-butanol 40 mmol⁄l, and the PKC inhibitors chelerythrine 1 μmol⁄l and calphostin C 100 nmol⁄l and completely blocked the increase in oxidative stress induced by pressure. Carvedilol 1 μmol⁄l but not propranolol 1 μmol⁄l blocked pressure-induced increases in oxidative stress in cultured SMCs. These findings suggest that pressure increases oxidative stress and that carvedilol significantly inhibits pressure-induced increase in oxidative stress in cultured human coronary smooth muscle cells. (Hypertens Res 2002; 25: 419-425)

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (43)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ